Trial intelligence / Profile preview

Phase IV study of Suhuang Zhike Capsule for post-infectious cough

ChiCTR1900025305Phase 4Not yet recruiting

Sponsor
China-Japan Friendship Hospital
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of suhuang antitussive capsule in postinfectious cough, sponsored by China-Japan Friendship Hospital. Primary endpoints: 12-lead electrocardiogram, Chest X-ray examination and 5 more. Planned start Apr 2019; status: not yet recruiting.

02

Drugs

suhuang antitussive capsule
03

Conditions

postinfectious cough

Beyond the preview

Go deeper on ChiCTR1900025305.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900025305.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call